Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Anemia

Free Subscription Articles published in Int J Hematol Retrieve available abstracts of 46 articles: HTML format

Single Articles

November 2025
1. KOMATSU N, Ito K, Arita K, Mitobe Y, et al
   Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.
   Int J Hematol. 2025 Nov 14. doi: 10.1007/s12185-025-04108.
   PubMed     Abstract available
   
   
   
2. MANGANAS K, Delicou S, Hadziyannis E, Giannouli S, et al
   Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease.
   Int J Hematol. 2025;122:637-646.
   PubMed     Abstract available
   
   
   August 2025
3. GROVER P, S A
   Efficacy of alternate day versus daily oral iron therapy in children with iron deficiency anemia: a randomized controlled trial.
   Int J Hematol. 2025 Aug 17. doi: 10.1007/s12185-025-04048.
   PubMed     Abstract available
   
   
   July 2025
4. YOON SS, Chen CC, Lee SE, Chang H, et al
   Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.
   Int J Hematol. 2025 Jul 21. doi: 10.1007/s12185-025-04037.
   PubMed     Abstract available
   
   
   June 2025
5. IMASHUKU S, Kazuma Y, Chonabayashi K, Shimazu Y, et al
   Myelodysplastic syndrome with ring chromosomes in a case of dehydrated hereditary stomatocytosis 1 (DHS1).
   Int J Hematol. 2025;121:857-861.
   PubMed     Abstract available
   
   
   May 2025
6. WANG X, Qin X, Luo C, Luo C, et al
   Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia.
   Int J Hematol. 2025 May 23. doi: 10.1007/s12185-025-03971.
   PubMed     Abstract available
   
   
   April 2025
7. CHARITAKI E, Liapis K
   Spherocytic hemolytic anemia caused by Clostridium perfringens.
   Int J Hematol. 2025 Apr 15. doi: 10.1007/s12185-025-03993.
   PubMed    
   
   
   
8. TOKUSHIGE J, Taoka K, Nishikawa M, Jona M, et al
   Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria.
   Int J Hematol. 2025;121:543-546.
   PubMed     Abstract available
   
   
   
9. RAO M, Luo W, Wu B
   The medium-fluorescence reticulocyte ratio is an independent predictor of G6PD deficiency neonates.
   Int J Hematol. 2025;121:526-532.
   PubMed     Abstract available
   
   
   February 2025
10. YAMAMOTO R, Hiramoto N, Nagai Y, Ishikawa T, et al
    Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.
    Int J Hematol. 2025 Feb 12. doi: 10.1007/s12185-025-03940.
    PubMed     Abstract available
    
    
    
11. MOMBO LE, Moreau BD, Bisseye C, Mikelet Boussoukou IP, et al
    Screening for sickle cell anemia in two populations of eastern Gabon using alkaline electrophoresis and hemoglobin level combined with leukocyte count.
    Int J Hematol. 2025 Feb 5. doi: 10.1007/s12185-025-03934.
    PubMed     Abstract available
    
    
    January 2025
12. KOSUGI H, Fujisaki T, Iwasaki H, Shinagawa A, et al
    A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
    Int J Hematol. 2025;121:68-78.
    PubMed     Abstract available
    
    
    
13. EDAHIRO Y, Komatsu N
    Iron deficiency and phlebotomy in patients with polycythemia vera.
    Int J Hematol. 2025;121:39-44.
    PubMed     Abstract available
    
    
    December 2024
14. EGUCHI K, Ishimura M, Ohga S, Endo S, et al
    Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia.
    Int J Hematol. 2024 Dec 27. doi: 10.1007/s12185-024-03903.
    PubMed     Abstract available
    
    
    
15. MOMOEDA M, Ito K, Inoue S, Shibahara H, et al
    Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia.
    Int J Hematol. 2024 Dec 26. doi: 10.1007/s12185-024-03905.
    PubMed     Abstract available
    
    
    
16. MIYAKAWA Y, Sato E, Ogawa Y, Nishimura JI, et al
    Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease.
    Int J Hematol. 2024;120:656-664.
    PubMed     Abstract available
    
    
    
17. SATO K, Nakamura Y, Hara R, Kayama R, et al
    Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab.
    Int J Hematol. 2024;120:735-742.
    PubMed     Abstract available
    
    
    November 2024
18. AL-JUBOURI AM, Eliwa A, Haithm Y, Al-Qahtani N, et al
    Relationship between hemoglobinopathies and male infertility: a scoping review.
    Int J Hematol. 2024;120:566-574.
    PubMed     Abstract available
    
    
    September 2024
19. SAEIDNIA M, Shadfar F, Sharifi S, Babashahi M, et al
    Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach.
    Int J Hematol. 2024;120:271-277.
    PubMed     Abstract available
    
    
    May 2024
20. KOSUGI M, Takezawa R, Shiota S, Tsuchikawa M, et al
    Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments.
    Int J Hematol. 2024 May 28. doi: 10.1007/s12185-024-03801.
    PubMed     Abstract available
    
    
    April 2024
21. WU LS, Luo X, Tan M, Zhang LJ, et al
    Prevalence of thalassemia-carrier couples and fertility risk assessment.
    Int J Hematol. 2024;119:374-382.
    PubMed     Abstract available
    
    
    March 2024
22. SAWADA Y, Sakamoto K, Tsukamura A, Sawai C, et al
    Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet.
    Int J Hematol. 2024 Mar 25. doi: 10.1007/s12185-024-03759.
    PubMed     Abstract available
    
    
    
23. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03739.
    PubMed    
    
    
    
24. OBARA N, Usuki K, Hayashi T, Fujii M, et al
    Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors.
    Int J Hematol. 2024;119:255-264.
    PubMed     Abstract available
    
    
    
25. NAKAO S
    Diagnosis of immune pathophysiology in patients with bone marrow failure.
    Int J Hematol. 2024;119:231-239.
    PubMed     Abstract available
    
    
    February 2024
26. SCHEINBERG P
    Progress in medical therapy in aplastic anemia: why it took so long?
    Int J Hematol. 2024 Feb 26. doi: 10.1007/s12185-024-03713.
    PubMed     Abstract available
    
    
    
27. ONISHI Y
    Aplastic anemia: history and recent developments in diagnosis and treatment.
    Int J Hematol. 2024 Feb 4. doi: 10.1007/s12185-024-03715.
    PubMed     Abstract available
    
    
    January 2024
28. IGUCHI A, Uchiyama T, Fujimori K, Gocho Y, et al
    HLA-haploidentical T-cell receptor alphabetaT/B-cell-depleted stem cell transplantation for Fanconi anemia.
    Int J Hematol. 2024 Jan 16. doi: 10.1007/s12185-023-03703.
    PubMed     Abstract available
    
    
    
29. KASHIWAGI H, Kuwana M, Murata M, Shimada N, et al
    Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.
    Int J Hematol. 2024;119:1-13.
    PubMed     Abstract available
    
    
    December 2023
30. MAKITA S, Ota S, Mishima Y, Usuki K, et al
    Japanese phase Ib study of the oral PI3K-delta and -gamma inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Int J Hematol. 2023 Dec 27. doi: 10.1007/s12185-023-03689.
    PubMed     Abstract available
    
    
    
31. ZHENG J, Gao L, Liu H, Xiao P, et al
    Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Int J Hematol. 2023 Dec 21. doi: 10.1007/s12185-023-03676.
    PubMed     Abstract available
    
    
    
32. MIKI K, Ogasawara R, Sugimura S, Sugita J, et al
    A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.
    Int J Hematol. 2023;118:766-771.
    PubMed     Abstract available
    
    
    October 2023
33. SHINN LT, Benitez LL, Perissinotti AJ, Reid JH, et al
    Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
    Int J Hematol. 2023 Oct 26. doi: 10.1007/s12185-023-03670.
    PubMed     Abstract available
    
    
    
34. FUKATSU M, Hamazaki Y, Sato Y, Koyama D, et al
    A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Int J Hematol. 2023;118:472-476.
    PubMed     Abstract available
    
    
    
35. NISHIMURA JI, Kawaguchi T, Ito S, Murai H, et al
    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
    Int J Hematol. 2023;118:419-431.
    PubMed     Abstract available
    
    
    September 2023
36. CHATZIKALIL E, Kattamis A, Diamantopoulos P, Solomou EE, et al
    New-onset aplastic anemia after SARS-CoV-2 vaccination.
    Int J Hematol. 2023 Sep 28. doi: 10.1007/s12185-023-03666.
    PubMed     Abstract available
    
    
    
37. LI H, Wang J, Wang D, Gan Y, et al
    Ten years' experience in prenatal diagnosis of alpha-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Int J Hematol. 2023;118:355-363.
    PubMed     Abstract available
    
    
    
38. USUKI K, Ikezoe T, Ishiyama K, Kanda Y, et al
    Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2023;118:311-322.
    PubMed     Abstract available
    
    
    
39. WANG P, Yang S
    Clonal cytopenia of undetermined significance presenting with multiple duplications of chromosome 1q.
    Int J Hematol. 2023;118:307-308.
    PubMed    
    
    
    July 2023
40. EDAHIRO Y, Ochiai T, Hashimoto Y, Morishita S, et al
    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Int J Hematol. 2023;118:47-53.
    PubMed     Abstract available
    
    
    May 2023
41. KOBAYASHI M, Mori A, Oda Y, Yokoyama E, et al
    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2023 May 23:1-6. doi: 10.1007/s12185-023-03618.
    PubMed     Abstract available
    
    
    April 2023
42. SALES RR, Luizon MR
    Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies.
    Int J Hematol. 2023;117:626-627.
    PubMed    
    
    
    
43. YAMANO S, Iguchi A, Ishikawa K, Sakamoto A, et al
    Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Int J Hematol. 2023;117:622-625.
    PubMed     Abstract available
    
    
    
44. SUZUKI Y, Shiba T
    Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination.
    Int J Hematol. 2023;117:618-621.
    PubMed     Abstract available
    
    
    March 2023
45. YOSHIDA N
    Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
    Int J Hematol. 2023 Mar 3. doi: 10.1007/s12185-023-03564.
    PubMed     Abstract available
    
    
    
46. KUBO M, Matsumoto M
    Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Int J Hematol. 2023;117:331-340.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.